NCT01137643
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +98 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
Clinical trial condition
Lymphoma, Extranodal NK-T-Cell
Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.
160 public trials
17 recruiting studies
Lymphoma, Extranodal NK-T-Cell trial results
NCT07000617
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
- Peking University Cancer Hospital Beijing, China
- Peking University International Hospital Beijing, China
NCT06824883
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT06732492
- Conditions
- CART Therapy, CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies, Lymphoma, +6 more
- Locations
-
- Union Hospital Wuhan, Hubei, China
NCT05662540
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
NCT05833893
- Conditions
- Advanced Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +6 more
- Locations
-
- ChinaPLAGH Beijing, Haidian, China
NCT02859402
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Dong-A University Busan, South Korea
- Keimyung University Dongsan Medical Center Daegu, South Korea
Not yet recruiting
A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma
NCT07791615
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not yet recruiting
GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma
NCT07768943
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not yet recruiting
TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma
NCT07639879
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +5 more
- Locations
-
- Peking University Cancer Hospital Beijin, Beijing Municipality, China